EMBL Australia

EMBL Australia researchers have made an exciting breakthrough in the field of regenerative medicine, offering new hope for safer and more effective treatments.

The recent EMBL Australia training event at Monash University, ‘Beyond Imaging: Visualisation, analysis & inference’, proved a hit with the local imaging community, with many keen to see the event return and expand.

PhD students Bec Degnan and Bonnie Werner share the benefits of travelling to EMBL Heidelberg with an EMBL Australia travel grant, including newfound confidence in science communication and inspiration to change research direction.

EMBL Australia and Burnet Institute group leader Dr Michelle Boyle has been awarded Australia’s largest philanthropic biomedical fellowship to support her research into malaria immunity.

Dr William Roman will begin as an EMBL Australia Group Leader, based at the Australian Regenerative Medicine Institute, Monash University, in May.

News this quarter:

• Register now for our free light-sheet microscopy workshop
• Two group leaders join our alumni network
• Recruiting an EMBL Australia Group Leader in cancer research
• Our Gender Equity, Diversity & Inclusion Action Plan is live
• Welcoming new members to the EMBL Australia Council
• SAVE THE DATE: PhD Course 2023
• Our researchers were awarded $6.27m in NHMRC Ideas Grants
• New insights into equitable & symmetrical cell division
• Get to know… Dr William Roman

And more:

• Job opportunities
• Student opportunities
• Upcoming events
• Recent publications

We’re excited to welcome three new members – Professor Helen Thomas, Professor Jennifer Stow and Ms Erica Kneipp – to the EMBL Australia Council, as we bid a fond farewell to Professor Andrew Sinclair and Dr David Hansen.

Farewell to Professor David Lynn and Associate Professor Ville-Petteri Mäkinen, who have successfully completed their nine-year terms as EMBL Australia group leaders.

EMBL Australia group leader Dr Vaishnavi Ananthanarayanan and her team uncover the mechanism that facilitates symmetrical cell division.

The highly competitive grants will fund innovative research projects to advance a wide range of health issues, including tissue regeneration, immune responses to vaccination, mRNA therapeutics and suppressing cancer growth.